Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Lantern Pharma Inc |
4/02 | 4,800 USD
+2,78% |
+2,78% |
|
Lantheus Holdings Inc |
4/02 | 91,800 USD
+2,52% |
+2,52% |
|
Larimar Therapeutics Inc |
4/02 | 3,670 USD
+3,38% |
+3,38% |
|
Leap Therapeutics Inc |
4/02 | 0,538 USD
+2,73% |
+2,73% |
|
Legend Biotech Corp |
4/02 | 37,840 USD
+1,42% |
+1,42% |
|
Lemaitre Vascular Inc |
4/02 | 97,460 USD
+2,13% |
+2,13% |
|
LENSAR Inc |
4/02 | 11,250 USD
+5,63% |
+5,63% |
|
Lexicon Pharmaceuticals Inc |
4/02 | 0,760 USD
+4,50% |
+4,50% |
|
Lifevantage Corporation |
4/02 | 23,740 USD
+9,75% |
+9,75% |
|
Ligand Pharmaceuticals, Inc. |
4/02 | 117,260 USD
+2,18% |
+2,18% |
|
Lineage Cell Therapeutics Inc |
4/02 | 0,660 USD
-4,29% |
-4,29% |
|
Lipocine Inc |
4/02 | 4,540 USD
+4,13% |
+4,13% |
|
Liquidia Corp |
4/02 | 15,150 USD
+5,72% |
+5,72% |
|
LivaNova PLC |
4/02 | 48,250 USD
+0,40% |
+0,40% |
|
Lixte Biotechnology Holdings Inc |
4/02 | 2,882 USD
+5,19% |
+5,19% |
Lumibird |
3/02 | 7,500 EUR
-2,60% |
-2,60% |
|
Lumos Pharma Inc |
11/12 | 4,340 USD
0,00% |
0,00% |
|
Lyra Therapeutics Inc |
4/02 | 0,183 USD
+0,55% |
+0,55% |